Abstract
Background and Aims: It is well established that HDL particles have antiatherogenic properties. However, there are conflicting evidence in regards to HDL particle function and its association with various CVD risk factors. The aim of our study was to analyze associations between the marker of HDL function - cholesterol efflux capacity (CEC) and traditional (age, serum lipids, CRP) and emerging (monocyte-platelet aggregates (MPAs)) CVD risk markers.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
